technician JULIET A HAYNE, McSP, senior physiotherapist R N BAIRD, CHM, FRCS, consultant senior lecturer in surgery also felt much healthier, having unduly restricted their activities before because they had feared the onset of ischaemic leg pain.
present in the dermis (fig 4) . The increased zinc concentration in lente and protamine zinc preparations or the presence of fish protamine in isophane and protamine zinc insulins may enhance the immunological response to injected insulin.18 The remarkable female preponderance in this and other series of patients with lipoatrophy is difficult to explain immunologically. Lipoatrophy may be more obvious in women, in whom there is more subcutaneous tissue available for dramatic change.
Lipoatrophy at sites remote from injection, such as the breasts and face, has occasionally been reported and is difficult to explain by any theory of insulin-induced lipoatrophy. We think it much more likely that if such cases occur they represent the coexistence of insulin-dependent diabetes with some other form of lipodystrophy.19 20
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Acta Med Scand [Suppni 1976; 601:197-245 . to show a significant increase in calf blood flow after exercise training by either using xenon-133 clearance3 or testing with venous-occlusion straingauge plethysmography.4 Improvement in walking distance cannot therefore be ascribed to increased blood flow from the development of collaterals, as some have suggested.' Other proposed mechanisms include redistribution of muscle blood flow within the leg, increased metabolic activity in exercisetrained skeletal muscle,8 improved walking efficiency, and increased pain tolerance, but there is little evidence to support any of these explanations.
A diet and exercise regimen was recently shown to improve mental acuity and to have beneficial effects on psychological factors and personality in elderly people with cardiovascular disease.9 Our patients felt physically and mentally much better as their exercise ability improved. They also remarked on the benefits of meeting other people with a similar mild disease in contrast with those met in the vascular clinic waiting area, who occasionally included amputees. The class developed a group identity, and each member was encouraged by the group's success. Many patients-aware and afraid of claudication-had curtailed any exercise so that they stopped walking before pain developed. Under supervision and encouraged by others in the group, however, they would continue for longer after the onset of pain.
We believe that similar training at home would have been less effective than the exercise class. As others have found,6 the improvement in symptoms was unrelated to the sites of arterial lesions and occurred with both aortoiliac and femoropopliteal occlusive disease. The rate of surgical intervention (10%) was similar to that in other studies. 10 The improvement in walking distance occurred without the use of vasodilators, though most patients had already taken these drugs with varying effect. Although this study was confined to patients with intermittent claudication, Foley' and Jonason et al' showed that patients with ischaemic rest pain or even trophic changes could benefit from exercise training. Less improvement would be likely in elderly patients or those with combined limb ischaemia and cardiorespiratory disease. Patients with neurogenic claudication would probably not benefit at all, which emphasises the importance of confirming the haemodynamic effects of limb ischaemia in a vascular laboratory if the clinical diagnosis of claudication is in doubt. We report the case of a patient with primary hyperparathyroidism in which the presenting symptoms included unilateral visual failure. This recovered completely after removal of a parathyroid adenoma.
Case report
A 47-year-old housewife presented with a midline palatal swelling for 10 weeks. She also complained that vision in her right eye had been diminishing over four weeks. She had had sciatica two years previously and still had diffuse back pain. She was edentulous, wearing full upper and lower dentures. There was a smooth, fairly soft swelling 3 cm x 1-5 cm in the midline at the posterior aspect of the hard palate, displacing the upper denture, and two small fusiform swellings on the lateral aspects of the maxillary alveolus in the incisor regions. Slight localised bossing of the left frontal bone was apparent. Visual acuity in the right eye was very poor and deteriorated to perception of light over 10 days. Corneal calcification was noted bilaterally at the limbal equator. The retinal arteries in the right eye appeared slightly attenuated and the pupil was sluggish, but there was no lens opacity, myopia, proptosis, impairment of ocular movement, or papilloedema and no ocular lesion sufficient to account for the loss of vision. Visual acuity in the left eye was normal. X-ray examination showed ill-defined radiolucent areas in the maxillary alveolus coinciding with the fusiform swellings. The right optic foramen appeared on tomograms as an ill-defined region of radiolucency with no clear margin. The left optic foramen appeared normal. The phalanges showed subperiosteal erosions. There were cystic changes in the pelvic girdle, ribs, and frontal bone.
Serum concentrations measured were as follows: calcium 3-85 mmol/l (15-4 mg/100 ml) (normal 2-1-2-6 mmol/l (8-4-10-4 mg/100 ml)); phosphate 0-72 mmol/l (2-3 mg/100 ml) (normal 0-8-1-4 mmol/l (2-5-4-5 mg/100 ml)); albumin 45 g/l (normal 34-50 g/l); alkaline phosphatase 303 IU/l (normal 20-90 IU/1); parathyroid hormone 6-65 ,ug/l (normal <1.0 ,Lg/l) by radioimmunoassay using a human parathyroid hormone standard; creatinine 91 pmol/l (1.03 mg/100 ml) (normal 50-120 ,umol/l (0-56-1-35 mg/100 ml)).
An excision biopsy specimen of the palatal swelling showed a vascular, fleshy tumour completely eroding the bone of the hard palate, macroscopically typical of a giant-cell lesion. Histologically it was a giant-cell lesion containing a large amount of osteoid, some showing early ossification.
A large single tumour of the left inferior parathyroid gland weighing six grams was removed. Histologically it was typical of a parathyroid chief-cell adenoma. Postoperatively all the biochemical abnormalities resolved. She was given 0-5-2 tLg l-alphahydroxycholecalciferol daily for 12 weeks, by when the alkaline phosphatase concentration had returned to normal. Radiological healing of the skeletal lesions was subsequently confirmed. In particular, the right optic foramen became sharply defined, normal in size, and with a slightly sclerotic border. Vision returned in the right eye within two weeks of the parathyroidectomy. Acuity was 6/9 after six weeks and 6/5 after five months.
Comment
This patient had skeletal changes affecting many bones because of primary hyperparathyroidism. The palatal giant-cell tumour was typical of lesions described in this condition and well known to affect the jaw bones.' Corneal calcification is associated with hypercalcaemia2 and papilloedema has been reported,3 but visual failure due to hyperparathyroidism has not been recorded. It may have resulted from distortion of the neurovascular bundle in the optic canal by another giant-cell tumour, and this hypothesis is supported by the return of vision and restoration ofthe optic foramen (radiologically) that followed removal of the parathyroid adenoma. 
Case report
A 2-year-old girl presented with purpura. One month earlier she had had a fever, but the cause was not known. Physical examination showed purpura, enlarged lymph nodes, and mild hepatosplenomegaly. The platelet count was 10-20 x 109/l1 (10 000-20 000/mm3). The result of bone marrow examination was unhelpful. After a short course of steroid treatment the purpura and thrombocytopenia disappeared. A Sabin-Feldman dye test, performed because of an enlarged spleen and liver and lymphadenopathy, was positive at a titre of 1/4096. Three months later the titre was 1/1024, and one year later 1/256.
